全文获取类型
收费全文 | 284篇 |
免费 | 26篇 |
国内免费 | 1篇 |
专业分类
儿科学 | 12篇 |
妇产科学 | 13篇 |
基础医学 | 35篇 |
口腔科学 | 12篇 |
临床医学 | 62篇 |
内科学 | 51篇 |
皮肤病学 | 1篇 |
神经病学 | 20篇 |
特种医学 | 3篇 |
外科学 | 17篇 |
综合类 | 1篇 |
一般理论 | 1篇 |
预防医学 | 40篇 |
眼科学 | 1篇 |
药学 | 27篇 |
肿瘤学 | 15篇 |
出版年
2023年 | 2篇 |
2022年 | 2篇 |
2021年 | 7篇 |
2020年 | 5篇 |
2019年 | 10篇 |
2018年 | 5篇 |
2017年 | 9篇 |
2016年 | 2篇 |
2015年 | 4篇 |
2014年 | 8篇 |
2013年 | 18篇 |
2012年 | 20篇 |
2011年 | 20篇 |
2010年 | 6篇 |
2009年 | 6篇 |
2008年 | 17篇 |
2007年 | 23篇 |
2006年 | 11篇 |
2005年 | 16篇 |
2004年 | 25篇 |
2003年 | 26篇 |
2002年 | 9篇 |
2001年 | 4篇 |
2000年 | 6篇 |
1999年 | 5篇 |
1998年 | 3篇 |
1997年 | 7篇 |
1996年 | 2篇 |
1994年 | 1篇 |
1993年 | 2篇 |
1990年 | 3篇 |
1989年 | 3篇 |
1988年 | 2篇 |
1987年 | 5篇 |
1986年 | 2篇 |
1985年 | 2篇 |
1984年 | 1篇 |
1982年 | 2篇 |
1981年 | 5篇 |
1980年 | 2篇 |
1978年 | 1篇 |
1974年 | 1篇 |
1969年 | 1篇 |
排序方式: 共有311条查询结果,搜索用时 0 毫秒
31.
Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains 下载免费PDF全文
Zhao-hai Lu Joanne F. Berson Ying-hua Chen Julie D. Turner Tian-yuan Zhang Matthew Sharron M. Harley Jenks Zi-xuan Wang Jin Kim Joseph Rucker James A. Hoxie Stephen C. Peiper Robert W. Doms 《Proceedings of the National Academy of Sciences of the United States of America》1997,94(12):6426-6431
The chemokine receptor CXCR4 functions as a fusion coreceptor for T cell tropic and dual-tropic HIV-1 strains. To identify regions of CXCR4 that are important for coreceptor function, CXCR4–CXCR2 receptor chimeras were tested for the ability to support HIV-1 envelope (env) protein-mediated membrane fusion. Receptor chimeras containing the first and second extracellular loops of CXCR4 supported fusion by T tropic and dual-tropic HIV-1 and HIV-2 strains and binding of a monoclonal antibody to CXCR4, 12G5, that blocks CXCR4-dependent infection by some virus strains. The second extracellular loop of CXCR4 was sufficient to confer coreceptor function to CXCR2 for most virus strains tested but did not support binding of 12G5. Truncation of the CXCR4 cytoplasmic tail or mutation of a conserved DRY motif in the second intracellular loop did not affect coreceptor function, indicating that phosphorylation of the cytoplasmic tail and the DRY motif are not required for coreceptor function. The results implicate the involvement of multiple CXCR4 domains in HIV-1 coreceptor function, especially the second extracellular loop, though the structural requirements for coreceptor function were somewhat variable for different env proteins. Finally, a hybrid receptor in which the amino terminus of CXCR4 was replaced by that of CCR5 was active as a coreceptor for M tropic, T tropic, and dual-tropic env proteins. We propose that dual tropism may evolve in CCR5-restricted HIV-1 strains through acquisition of the ability to utilize the first and second extracellular loops of CXCR4 while retaining the ability to interact with the CCR5 amino-terminal domain. 相似文献
32.
GW627368X ((N-{2-[4-(4,9-diethoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl]acetyl} benzene sulphonamide): a novel, potent and selective prostanoid EP4 receptor antagonist 下载免费PDF全文
Wilson RJ Giblin GM Roomans S Rhodes SA Cartwright KA Shield VJ Brown J Wise A Chowdhury J Pritchard S Coote J Noel LS Kenakin T Burns-Kurtis CL Morrison V Gray DW Giles H 《British journal of pharmacology》2006,148(3):326-339
1. N-{2-[4-(4,9-diethoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl]acetyl}benzene sulphonamide (GW627368X) is a novel, potent and selective competitive antagonist of prostanoid EP4 receptors with additional human TP receptor affinity. 2. At recombinant human prostanoid EP4 receptors expressed in HEK293 cells, GW627368X produced parallel rightward shifts of PGE2 concentration-effect (E/[A]) curves resulting in an affinity (pKb) estimate of 7.9 +/- 0.4 and a Schild slpoe not significantly different from unity. The affinity was independent of the agonist used. 4. In rings of phenylephrine precontracted piglet saphenous vein, GW627368X (30-300 nM) produced parallel rightward displacement of PGE2 E/[A] curves (pKb = 9.2 +/- 0.2; slope = 1). 4. GW627368X appears to bind to human prostanoid TP receptors but not the TP receptors of other species. In human washed platelets, GW627368X (10 microM) produced 100% inhibition of U-46619 (EC100)-induced aggregation (approximate pA2 approximately 7.0). However, in rings of rabbit and piglet saphenous vein and of guinea-pig aorta GW627368X (10 microM) did not displace U-46619 E/[A] curves indicating an affinity of < 5.0 for rabbit and guinea-pig prostanoid TP receptors. 5. In functional assays GW627368X is devoid of both agonism and antagonist affinity for prostanoid CRTH2, EP2, EP3, IP and FP receptors. At prostanoid EP1 receptors, GW627368X was an antagonist with a pA2 of 6.0, and at prostanoid IP receptors the compound increased the maximum effect of iloprost by 55%. At rabbit prostanoid EP2 receptors the pA2 of GW627368X was < 5.0. 6. In competition radioligand bioassays, GW627368X had affinity for human prostanoid EP4 and TP receptors (pKi = 7.0 +/- 0.2 (n = 10) and 6.8 (n = 2), respectively). Affinity for all other human prostanoid receptors was < 5.3. 7. GW627368X will be a valuable tool to explore the role of the prostanoid EP4 receptor in many physiological and pathological settings. 相似文献
33.
34.
Sildenafil citrate is marketed under the trademark name Viagra and is widely used to treat male erectile dysfunction; therapeutic uses of this medication for other diseases related to vascular dysfunction are emerging. When used as recommended, the drug has a strong clinical efficacy and safety profile in a broad spectrum of the male population. Its widespread use and effects of long-term exposure to the drug due to particular treatment regimens or inappropriate use mandate an ongoing update of its molecular mechanism, pharmacological profile and associated safety issues. This review focuses on biochemical and pharmacological features of sildenafil, the active component in Viagra, interaction of sildenafil with phosphodiesterase 5, pharmacokinetic parameters, action in smooth muscle, side effects, safety profile and prospects for other uses. 相似文献
35.
36.
37.
38.
Whether male researchers can conduct qualitative research with female participants, and interpret accounts of their lives, is a contentious issue within the feminist literature. Academics and activists argue that not all researchers are uniformly positioned, in terms of social location, or possess the necessary lived experiences to conduct feminist research. Conducting research into sexuality can intensify these concerns, with such projects perceived as 'riskier' and establishing trust in the research setting more difficult than with mainstream topics. This paper draws on data from research interviews that explored women's understandings of sexuality, sex and sexual problems to discuss participants' views of being interviewed by a gay man. It highlights that the shared experience of marginality was a key influence upon the interview interaction, particularly regarding levels of empathy, and this facilitated disclosure. By providing a reflexive account of the gendered and sexual orientation dynamics of conducting research interviews, we argue that focusing solely upon gender similarity as a pre-requisite for conducting feminist research with female participants fails to acknowledge the role of other factors that enable 'good' research to be done. 相似文献
39.
Wilson M Mowat D Dastot-Le Moal F Cacheux V Kääriäinen H Cass D Donnai D Clayton-Smith J Townshend S Curry C Gattas M Braddock S Kerr B Aftimos S Zehnwirth H Barrey C Goossens M 《American journal of medical genetics. Part A》2003,(3):257-265
Mutations or deletions involving ZFHX1B (previously SIP1) have recently been found to cause one form of syndromic Hirschsprung disease (HSCR), associated with microcephaly, mental retardation, and distinctive facial features. Patients with the characteristic facial phenotype and severe mental retardation, but without HSCR, have now also been shown to have mutations in this gene. Mutations of ZFHX1B are frequently associated with other congenital anomalies, including congenital heart disease, hypospadias, renal tract anomalies, and agenesis of the corpus callosum (ACC). We present the clinical data and mutation analysis results from a series of 23 patients with this clinical syndrome, of whom 21 have proven ZFHX1B mutations or deletions (15 previously unpublished). Two patients with the typical features (one with and one without HSCR) did not have detectable abnormalities of ZFHX1B. We emphasize that this syndrome can be recognized by the facial phenotype in the absence of either HSCR or other congenital anomalies, and needs to be considered in the differential diagnosis of dysmorphism with severe mental retardation +/- epilepsy. 相似文献